Michael York

Cardioprotection with dexrazoxane for doxorubicin-containing therapy in advanced breast cancer.

Sandra M. Swain, Fredrick S. Whaley, Mirjam C. Gerber et al. · Journal of Clinical Oncology · 1997 · 652 citations

Medicine, Oncology, Pharmacology +16

Proteome-wide Analysis and CXCL4 as a Biomarker in Systemic Sclerosis

Lenny van Bon, Alsya J. Affandi, Jasper Broen et al. · New England Journal of Medicine · 2013 · 454 citations · Full text

Life Sciences, Immunology, Molecular Biology +16

Fresolimumab treatment decreases biomarkers and improves clinical symptoms in systemic sclerosis patients

Lisa Rice, Cristina M. Padilla, Sarah McLaughlin et al. · Journal of Clinical Investigation · 2015 · 344 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +17

A macrophage marker, siglec‐1, is increased on circulating monocytes in patients with systemic sclerosis and induced by type i interferons and toll‐like receptor agonists

Michael York, Taro Nagai, Alyson J. Mangini et al. · Arthritis & Rheumatism · 2007 · 322 citations

Life Sciences, Cell Biology, Immunology +17

B cell depletion with rituximab in patients with diffuse cutaneous systemic sclerosis

Robert Lafyatis, Eugene Y. Kissin, Michael York et al. · Arthritis & Rheumatism · 2009 · 284 citations · Full text

Medicine, Clinical Sciences, Immunology +13